JP2026027378A5 - - Google Patents
Info
- Publication number
- JP2026027378A5 JP2026027378A5 JP2025187819A JP2025187819A JP2026027378A5 JP 2026027378 A5 JP2026027378 A5 JP 2026027378A5 JP 2025187819 A JP2025187819 A JP 2025187819A JP 2025187819 A JP2025187819 A JP 2025187819A JP 2026027378 A5 JP2026027378 A5 JP 2026027378A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- peptide
- infection
- subject
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005999P | 2020-04-06 | 2020-04-06 | |
| US63/005,999 | 2020-04-06 | ||
| US202063045737P | 2020-06-29 | 2020-06-29 | |
| US63/045,737 | 2020-06-29 | ||
| US202063085771P | 2020-09-30 | 2020-09-30 | |
| US63/085,771 | 2020-09-30 | ||
| JP2022561206A JP2023521744A (ja) | 2020-04-06 | 2021-04-06 | 感染症における血行動態を変更する為の方法及び手段 |
| PCT/NL2021/050223 WO2021206547A1 (en) | 2020-04-06 | 2021-04-06 | Methods and means for modifying hemodynamics in infections |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561206A Division JP2023521744A (ja) | 2020-04-06 | 2021-04-06 | 感染症における血行動態を変更する為の方法及び手段 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026027378A JP2026027378A (ja) | 2026-02-18 |
| JP2026027378A5 true JP2026027378A5 (https=) | 2026-04-28 |
Family
ID=75581581
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561206A Pending JP2023521744A (ja) | 2020-04-06 | 2021-04-06 | 感染症における血行動態を変更する為の方法及び手段 |
| JP2025187819A Pending JP2026027378A (ja) | 2020-04-06 | 2025-11-06 | 感染症における血行動態を変更する為の方法及び手段 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561206A Pending JP2023521744A (ja) | 2020-04-06 | 2021-04-06 | 感染症における血行動態を変更する為の方法及び手段 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230241155A1 (https=) |
| EP (1) | EP4132556A1 (https=) |
| JP (2) | JP2023521744A (https=) |
| KR (1) | KR20230003495A (https=) |
| AU (1) | AU2021252821A1 (https=) |
| CA (1) | CA3174852A1 (https=) |
| CO (1) | CO2022015018A2 (https=) |
| MX (1) | MX2022012506A (https=) |
| WO (1) | WO2021206547A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4021481A1 (en) * | 2019-08-30 | 2022-07-06 | Biotempt B.V. | Q-er peptide |
| AU2021354766A1 (en) * | 2020-09-30 | 2023-05-11 | Biotempt B.V. | Autophagy-inhibiting peptide and organic acid salt thereof addressing issues of vascular permeability |
| WO2025191033A1 (en) | 2024-03-13 | 2025-09-18 | Biotempt B.V. | Per-operative treatment of post-operative complications (poc) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ542791A (en) * | 2003-04-08 | 2008-04-30 | Biotempt Bv | Compositions for mucosal and oral administration comprising HCG fragments |
| EP4021481A1 (en) * | 2019-08-30 | 2022-07-06 | Biotempt B.V. | Q-er peptide |
| CA3152346A1 (en) * | 2019-09-30 | 2021-04-08 | Roelof Peter Pickkers | Methods of treatment for modifying hemodynamics |
-
2021
- 2021-04-06 MX MX2022012506A patent/MX2022012506A/es unknown
- 2021-04-06 EP EP21720016.1A patent/EP4132556A1/en active Pending
- 2021-04-06 AU AU2021252821A patent/AU2021252821A1/en active Pending
- 2021-04-06 KR KR1020227038443A patent/KR20230003495A/ko active Pending
- 2021-04-06 WO PCT/NL2021/050223 patent/WO2021206547A1/en not_active Ceased
- 2021-04-06 US US17/995,692 patent/US20230241155A1/en active Pending
- 2021-04-06 JP JP2022561206A patent/JP2023521744A/ja active Pending
- 2021-04-06 CA CA3174852A patent/CA3174852A1/en active Pending
-
2022
- 2022-10-21 CO CONC2022/0015018A patent/CO2022015018A2/es unknown
-
2025
- 2025-11-06 JP JP2025187819A patent/JP2026027378A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026027378A5 (https=) | ||
| JP7399976B2 (ja) | Ｃｏｖｉｄ－１９新型コロナ肺炎を予防又は治療する医薬品、食品及びその使用 | |
| WO2021203702A1 (zh) | 焦谷氨酸在制备预防和治疗新冠肺炎新型冠状病毒的药物中的应用 | |
| RU2728939C1 (ru) | Применение даларгина для производства средств лечения коронавирусной инфекции covid-19 | |
| JP2023521744A5 (https=) | ||
| JP2023523557A5 (https=) | ||
| CN119700755B (zh) | 化合物在制备预防和/或治疗高原病的药物中的应用 | |
| Brain | Unlocking the opportunity of tight glycaemic control: Inhaled insulin: safety | |
| TW202203946A (zh) | 用於人或動物之慢性或急性之病毒感染症及/或敗血症之預防或治療的組成物 | |
| Techapornroong | Dengue hemorrhagic fever with acute liver failure, a case report with total plasma exchange therapy | |
| WO2021198346A2 (en) | Ezrin peptide 1 for use in a method of treating covid-19 | |
| JP2004529158A5 (https=) | ||
| CN113384688A (zh) | 一种糜蛋白酶在抗冠状病毒中的应用 | |
| RU2107498C1 (ru) | Способ лечения острых респираторных вирусных заболеваний и гриппа | |
| EP4125996B1 (en) | Ezrin peptide 1 for use in a method of treating covid-19 | |
| CN105326789B (zh) | 氨溴索沙丁胺醇溶液剂 | |
| JP6028968B2 (ja) | 抗インフルエンザウイルス剤 | |
| Mahadevappa et al. | Large right-sided pneumothorax with Takotsubo cardiomyopathy | |
| US20070238661A1 (en) | Substance P treatment for hepatitis C | |
| US20210346459A1 (en) | Application of Dalargin for the prevention of VRIs and prevention of the development of complications during VRIs | |
| SU1650140A1 (ru) | Способ лечени воспалительных заболеваний легких | |
| CN105326790B (zh) | 氨溴索沙丁胺醇溶液剂的制备方法 | |
| WO2023034282A1 (en) | Uses of propranolol for managing viral infections | |
| JP2024511660A (ja) | ポストｃｏｖｉｄ－１９を治療する方法における使用のためのエズリンペプチド１ | |
| Song et al. | Stress-induced Cardiomyopathy Associated with Swine Influenza Infection Which Exacerbated Underlying Emphysema: A Case Report |